Improving Laboratory Clinical Decision Making, Quality, Cost-Effectiveness and Diagnostic Efficiency!

Transcription

1 IBC LIFE SCIENCES 3 RD ANNUAL NOVEMBER 2016 Millennium Hotel Sirih Jakarta, Improving Laboratory Clinical Decision Making, Quality, Cost-Effectiveness and Diagnostic Efficiency! Keynote Government Address Mr Donald Pardede Senior Advisor to Minister of Health on Health Economics, Ministry of Health Featuring Insights From The Leading Experts: Drs. H. Sugihadi HW. MM Chairman of GAKESLAB, The n Association of Medical & Laboratory Appliances Enterprises, Prof Dr. Ida Parwati SpPK(K) President, n Society of Clinical Pathology and Laboratory Medicine, Professor in Clinical Pathology and Laboratory Medicine, Dr Hasan Sadikin Bandung, KEY THEMES IN 2016: Government Initiatives, Hospital Facilities, Healthcare Plans and Current Outlook Medical devices, distribution, trade and manufacturing market update New Regulation and Device Registration Updates in Patient Pool, Statistics and Unmet Needs Laboratory Automation and Infectious Diseases Latest Innovation in Microbiology Diagnostics Clarity, Accuracy and Cost-effectiveness in Smart Microbiology Laboratory Design and Automation Cost-Effectiveness, Quality and Better Patient Outcomes Point-of- Care Testing and Decision Making Procurement Decision Making Process 2 Events Under 1 Roof! Co-located Events: Dr Leslie Lam Head & Senior Consultant, Laboratory Medicine, Ng Teng Fong General Hospital and Jurong Community Hospital, Jurong Health Services, Singapore Dr. dr. Ina Susianti Timan Sp.PK(K)Staff lecturer, Faculty of Medicine University of, RSUPN Dr Cipto Mangunkusumo National Referral Hospital, Dr July Kumalawati Faculty of Medicine, Clinical Pathology Department, University of, Associate Prof. Cherdchai Nopmaneejumruslers Assistant Dean in Quality Development and Vice Hospital Director, Siriraj Hospital, Thailand PRE-CONFERENCE FOCUS DAY 22 November :00am 4.30pm s Healthcare Market Access Produced by: Life Sciences Supporting Organisations: Media Partners: International Marketing Partner:

2 CONFERENCE DAY ONE 23 NOVEMBER 2016 Wednesday 8.00 Registration Opens & Morning Coffee 8.50 Welcome Address from IBC Asia Joint Plenary Sessions with Healthcare Summit s Healthcare Industry Overview 9.00 Plenary Chairperson s Opening Remarks 9.10 Government Initiatives, Hospital Facilities, Healthcare Plans and Current Outlook Tackling the issue of Hospital Beds in : current Government initiatives UHC implementation and integration: where are we now and GOVERNMENT ADDRESS where are we headed? 2019 outlook Mr Donald Pardede, Senior Advisor to Minister of Health on Health Economics, Ministry of Health 9.50 Asia s Developing Healthcare Markets Evaluating Opportunities and Challenges ASEAN Integration impact on regional healthcare systems Delivering healthcare services and meeting increasing demands ~ Where are the new developments in ~ Local vs foreign investment in healthcare and hospital facilities ~ Change of lifestyle ~ Shift in demographics and unmet needs analysis ~ Ageing populations ~ Availability of new technologies Optimising opportunities and future trends in healthcare facilities Attracting investment in ís healthcare facilities Stakeholder expectations and engagement Medical technology procurement systems, distribution policies and market access overview Entering the n healthcare market what are the different collaborations and conditions for product import in? Moderator: Yoshihiro Suwa, Principal, Leader of Healthcare Practice in Southeast Asia, PT. Roland Berger Strategy Consultants, Panelists: Kuen Loon Ho, Group CFO, Fullerton Healthcare Group, Singapore Dr Mulyo Hartana, CEO & President Director, Rumah Sakit Jogja International Hospital, LEADERSHIP PANEL DISCUSSION Joint Morning Networking Break Chairperson s Remarks Asia s Device & Diagnostics Market Regulatory Updates on IVD & Diagnostic Devices in : Distribution, Manufacturing and Procurement Overview of the medical device and diagnostics industry in Market entry policies for foreign companies and partnership opportunities Government initiatives and assistance in for the healthcare industry Upcoming new regulations on Halal IVD and diagnostic equipment Senior Representative,Directorate of Medical Device and Household Health Evaluation, Ministry of Health, MOH KEYNOTE ADDRESS Patient Pool, Statistics and Unmet Needs: Evaluating Opportunities for Medical Device and Diagnostics Overview of the medical device and diagnostics industry in Market entry policies for foreign companies and partnership opportunities Government initiatives and assistance in for the healthcare industry Upcoming new regulations on Halal IVD and diagnostic equipment Drs. H. Sugihadi HW. MM, Chairman, GAKESLAB, The n Association of Medical & Laboratory Appliances Enterprises, Innovation in Microbiology Diagnostics Joint Networking Lunch 2.00 Laboratory Design for Emerging Infectious Diseases Different strategies before TLA (total laboratory automation) Moving from islet automation to TLA Process improvement in TLA 2.40 Future of Tropical Disease Diagnosis: Can it be Cost- Effective and Fast? Tropical diseases epidemiology and distribution in Current capabilities of disease diagnosis, accuracy and costeffectiveness Tackling the burden of tropical diseases in through laboratory automation Future of tropical disease diagnosis in Prof Dr. Ida Parwati SpPK(K), President, n Society of Clinical Pathology and Laboratory Medicine, Professor in Clinical Pathology and Laboratory Medicine, Dr Hasan Sadikin Bandung, 3.20 Joint Afternoon Networking & Refreshment Break 4.00 Improving Pre-Analytical Quality for Laboratory Testing: The Right Result to the Right Patient at the Right Time The aim of quality in clinical laboratory: Understanding the different phases of testing process from pre-analytical to diagnosis Addressing communication, proper identification, patient s preparation, appropriate use of equipment and supplies for preanalytical phase testing Key consideration in collection techniques, infection control procedures, proper labeling, and good waste management Conducting internal audits or by external survey and standardised check-list to evaluate the pre-analytical phase quality Dr. July Kumalawati, Faculty of Medicine, Clinical Pathology Department, University of, Dr. Cipto Mangunkusumo Hospital, 4.40 : Clarity, Accuracy and Costeffectiveness To see disease inside the human body with high precision Hybrid Imaging High precision, co-registration, of images of internal body organ FUNCTION with those of their structural ANATOMY Collection of Hybrid Images of actual patient cases, by SPECT- CT with the Intevo 16 Case Study: Cost effectiveness of new technology and its contribution to better outcomes for our patients Dr. Antonio Garcia, Team Leader and Chair of the Department of Nuclear Medicine, Head,, Manila Doctors Hospital, Philippines 5.20 Chairperson s Summary and End of Day One

3 CONFERENCE DAY TWO 24 NOVEMBER 2016 Thursday 8.50 Registration Opens & Morning Coffee 9.00 Chairperson s Opening Remarks Lab Management 9.10 The Role of the Laboratory in Critical Results Notification Critical result reporting and notification by clinical laboratories to ensure patient safety Various regulations governing the reporting of critical results Strategies in meeting these requirements Dr Leslie Lam, Head & Senior Consultant, Laboratory Medicine, Ng Teng Fong General Hospital and Jurong Community Hospital, Jurong Health Services, Singapore 9.50 Balancing Lean Laboratory operations and Laboratory Quality for Large Hospitals What is the lean principle? How to implement lean principle in pre-analytic laboratory process? Shortening turnaround time and improving safety and quality What are challenges faced in implementing lean principle? Understanding some of the lean tools, such as match take time and cycle time, workload levelling, Poka yoke, Just in time etc. Associate Prof. Cherdchai Nopmaneejumruslers, Assistant Dean in Quality Development and Vice Hospital Director, Siriraj Hospital, Thailand Joint Morning Networking Break Quality Device Procurement Decisions and Selection: What are the Key Considerations? Key considerations for procurement of devices and technology for lab operations Regulatory landscape in Philippines regarding certain registrable medical devices and reagents KEY OPINION LEADERS PERSPECTIVES Case Study and experience in device procurement, ergonomics, user-friendliness and cost-effectives Dr Valerie Anne T. Tesoro, Division Head of Clinical Pathology, National Kidney and Transplant Institute, Philippines 2.00 Understanding Requirements for IQCP (Individualized Quality Control Plans) Understanding Clinical Laboratory Improvement Amendments (CLIA) Quality Control (QC) procedure Ensuring quality test results Customizing the Labís QC plan according to test method and use, environment, and personnel competency while providing for equivalent quality testing 2.40 Laboratory Certification and Accreditation: Internal and External Quality Assurance External quality assurance and associated key considerations for quality in results Recognizing the recurring cost of Bad Quality in the lab as a necessary step to delivering more value to Physicians Improving the lab performance: How to gather the right data, identifying and prioritizing projects Accreditation and certification for labs: regulation updates Dr. dr. Ina Susianti Timan, Sp.PK(K)Staff lecturer, Faculty of Medicine University of, RSUPN Dr Cipto Mangunkusumo National Referral Hospital, 3.20 Joint Afternoon Networking & Refreshment Break 4.00 ISO for Quality Management System for Diagnostics and Devices ISO regulatory requirements for medical devices Impact of the recent updates and key considerations for manufacturers and users Point-Of-Care Testing 4.40 Should We POCT Or Not? Current trend in POCT and how it influences patient care Key factors that one should consider in POCT implementation Personal POCT experience Joanne Lee, Principal Scientific Officer, Laboratory Medicine, Ng Teng Fong General Hospital and Jurong Community Hospital, Jurong Health Services, Singapore 5.20 Chairperson s Summary & End of Conference Joint Networking Lunch Beneficial for networking, hearing diverse outlooks and inputs on the Med Device Industry Vice President, R&D, Becton Dickinson Co. Good overview for medical devices from several viewpoints (R&D, QA, distribution) Quality Systems Manager, Perkin Elmer

4 s Healthcare Market Access The [Universal Healthcare Coverage] scheme aims to make healthcare accessible to the country s entire population of 255 million by 2019, part of the government s efforts to direct some of the benefits of strong economic growth into improved welfare. A total of 160 million people are so far members of the programme in the world s fourth most populous nation, and it has been credited with helping many since its 2014 launch. But it faces numerous challenges, from underfunding, to slow and patchy implementation, where the system has become a victim of its own success in densely populated areas, leading to long queues. In the remote and poor east of the country, the problems are different people may theoretically have access to healthcare under the JKN, but often there are not enough hospitals and doctors to provide it. ~ Channel NewsAsia, June 2016 PRE-CONFERENCE FOCUS DAY 22 NOVEMBER 2016 Tuesday 9:00am 4.30pm This pre-conference focus day titled s Healthcare Market Access is designed for professionals from hospitals, healthcare providers, medical device companies, pharma companies, insurance companies and technology providers to gain an overview of the healthcare market potential and opportunities in. It will also give and insight into how to access this burgeoning healthcare market successfully. KEY TOPICS TO DISCUSS: Private Participation in UHC Programmes: Current Status and Outlook ecatalogue Model, Pricing and Procurement Landscape in : 2019 and Foreign Investments and Partnerships Post UHC Pharma Panel: Pharmaceutical Market Outlook: Trends, Opportunities & Market Access Drug Pricing & Reimbursement Under BPJS Achieving Accessible, Affordable & Quality Healthcare in For Updates on this forum and the expert industry speakers, please visit: Programme at a Glance 2 Events Under 1 Roof! Co-located Events: Pre-Conference Focus Day Tuesday l 22 November 2016 s Healthcare Market Access Conference Day One Wednesday l 23 November 2016 Joint Morning Plenary Sessions Conference Day Two Thursday l 24 November 2016 KEY THEMES Private Participation in UHC Programmes ecatalogue Model, Pricing and Procurement in Refreshment Break s Healthcare Market Access Lab Management s Healthcare Industry Overview Lean Lab Operations Networking Break & Exhibition Showcase Healthcare Projects Updates and Technology Innovation KEY THEMES Pharma Panel: Pharmaceutical Market Outlook & Market Access Drug Pricing & Reimbursement Under BPJS Achieving Accessible, Affordable & Quality Healthcare Asia s Device & Diagnostics Market Innovation in Microbiology Diagnostics Hospital Trends, Facility Expansion and Investments in Improving Patient Experience Evolving Healthcare and Partnership Models Quality Point-Of-Care Testing Quality, Affordability and Safety Talent Development & Medical Education Strategic Hospital Operations & Procurement Chairman s Message Dear Distinguished Experts, Colleagues and Friends, I would like to sincerely welcome you to come and join us at the senior conference in focusing on providing better healthcare by enhancing the laboratory operations quality and diagnostics operational excellence at IBC s 3rd Annual Med Device Asia conference happening from November 2016 in Jakarta. We will start with a visionary joint plenary session between 3rd Annual Med Device Asia and 3rd Annual Healthcare conferences in the morning followed by a more focused conference in microbiology and clinical laboratory operations, diagnostic imaging, laboratory equipment, point-of-care testing and tackling tropical diseases in. You will be able to listen to both and global industry experts, KOLs and leaders in order to share experiences, learn best practices and uncover solutions to tackle the current challenges in s healthcare industry. You will also be able to evaluate and meet partners, service providers and equipment providers in one single place! The 2016 conference will take place from November 22nd through the 24th at the Millennium Hotel Sirih located in Jakarta. On behalf of the organising committee and Gakeslab, it would be a pleasure and honour to have you to join us. Drs. H. Sugihadi. HW. MM Chairman, Gakeslab

5 IBC LIFE SCIENCES 3 RD ANNUAL NOVEMBER 2016 Millennium Hotel Sirih Jakarta, IBC s 3rd Annual Med Device Asia is s leading healthcare decision making forum, collocated with the 3rd Annual Healthcare Summit, it aims to bring together Hospital Management, KOLs, Laboratories, Blood Banks, Healthcare Providers, Medical Centers, Clinics, Government, Medical Device & Equipment Companies, Diagnostic Companies and Technology Providers under 1 roof to discuss the opportunities and tackle the challenges to s burgeoning healthcare market! Held in the country home to the 4th largest population in the world with a Government progressively moving towards quality and insured healthcare provision for the entire population by 2019, 3rd Annual Med Device Asia from November, Jakarta, is the definitive place to showcase scientific advancements, innovative ideas, technologies, trends with regional Government, Diagnostic Companies, KOLs, Industry Associations and Clinicians to discuss ways of addressing the growing needs of the largest healthcare market in South East Asia. Private healthcare is also opening up revenue streams for foreign and non-traditional healthcare companies. For instance, the in-vitro diagnostics (IVD) sector has more foreign companies than domestic, with approximately 80 percent of the market held by multinationals The healthcare segment will remain a focal point for investors as streamlined processes like the implementation of e-catalogs or online pricing systems by the n government facilitate market entry. The system will help control medical device prices and create healthy competition among foreign and domestic suppliers in the country. Why You Can t Afford to Miss 3rd Annual Med Device Asia! Network with 250+ senior KOL and healthcare decision makers across 2 leading events Hear from 30+ senior healthcare experts as they share their expertise at this event Showcase your technologies and services in front of s key hospital, lab and diagnostic decision makers Optimize your learning experience across the 2 events by choosing and mapping out your sessions across 2 days Identify new trends and opportunities in the Diagnostics space in Asia Healthcare Innovation Editors, March 2015 SEE WHO IS ATTENDING! INDUSTRY Hospitals, Medical Centers, Clinics Laboratories 40% Blood Banks 10% Diagnostic Centers 10% Private Laboratories and Testing Services 10% Medical Device/Diagnostic Companies, OEMs, Biotech 10% Industry Associations, Research Institutes and Government 5% Distributors 5% Solution and Technology Providers 10% GEOGRAPHY 50% Singapore, Malaysia, Thailand, Philippines 20% China, Japan, Korea, Hong Kong and Taiwan 10% Europe, USA 15% Australia, New Zealand 3% RoW 2% SPONSORSHIP OPPORTUNITIES Raise awareness for your services available to Hospital and Lab Value Chain in! 1. Would you like to raise your visibility in the laboratory, testing and healthcare diagnostics industry? 2. Could you benefit from showcasing your products & services before key decision makers from hospitals, medical centers, diagnostic labs, blood banks and government? If so, we can help you achieve your goals, perhaps what you need is a branding opportunity at this event! Increase your reach through our extensive marketing campaign, targeted at your qualified business audience. For information about placing your brand & profile top-of-mind to key buyers, contact Yvonne Leong, Senior Business Development Manager on Tel: or yvonne.leong@ibcasia.com.sg